The company manufactures antiretrovirals, artemisinin-based combination therapies (ACTs) and Hepatitis medicines to treat HIV/AIDS, malaria and Hepatitis | THE INDEPENDENT | Cipla Qaulity Chemicals Ltd, the East African nation’s drug manufacturer, has said net profits surged nearly five times to Shs 13.9 billion for the six months ending September driven …
Read More »
The company recorded the first profit since listing on Uganda Securities Exchange in 2018 | THE INDEPENDENT | Cipla Quality Chemical Industries has reported a better performance for the period ended March 31, 2022, posting a net profit of Shs24bn compared to a loss of Shs10bn in 2020. This performance …
Read More »
The company is in the process of formulating a strategy to enable it achieve short term and long-term goals Kampala, Uganda | THE INDEPENDENT | Shareholders of Cipla Quality Chemical Industries Limited (CQCIL) are waiting to see how their company performs during the reign of the new chief executive officer …
Read More »
The company recorded Shs 2.8billion profit for the half year period Kampala, Uganda | ISAAC KHISA | Uganda’s drug manufacturer, Cipla Quality Chemicals Ltd, recovered Shs 2.5billion from the Zambian government for the drugs supplied in 2018, helping the company to record a profit from the second time since listing …
Read More »
The company’s trading price has tumbled to less than Shs100 per share, down from Shs 256.5 IPO level Kampala, Uganda | ISAAC KHISA | Shareholders of drug maker, Cipla Quality Chemicals Ltd will not earn a dividend for the second consecutive year even after reporting a more than 50% drop …
Read More »
The new appointment comes at the time the drug maker’s share price has fallen below the IPO price Kampala, Uganda | ISAAC KHISA | Cipla Quality Chemicals Ltd, the producer of human drugs including anti-malarial and anti-retroviral is now set to receive a new managing director, Ajay Kumar Pal to …
Read More »
A jump in cost of sales, administrative expenses largely to blame for the bad performance Kampala, Uganda | JULIUS BUSINGE | Shareholders of Cipla Quality Chemical Industries Limited will again wait to receive dividends after their company reporting Shs16bn net loss for the first six months ended Sept.30 compared to …
Read More »
Kampala, Uganda | THE INDEPENDENT | Drugs maker Cipla Quality Chemicals Limited (CiplaQCi) has announced that it has paid 4.7 billion Shillings to acquire what they described as the Human Care Business assets of Quality Chemicals Limited. According to Nevin Bradford, the executive director of Cipla Quality Chemicals Limited, the …
Read More »
Nevin Bradford has been the Chief Executive Officer for Cipla Quality Chemical Ltd since November 2013. The Independent’s Julius Businge interviewed him about their COVID-19 experience and general company operations. What has been your general business experience since March 2020 when the government of Uganda joined the rest of the …
Read More »
The company remains strong to deliver good performance going forward, officials say Kampala, Uganda | JULIUS BUSINGE | The Kampala-based drug manufacturer, Cipla Quality Chemical Industries Ltd, has recorded a Shs36bn loss for the financial year 2019/20 compared to a profit of Shs7bn recorded in the previous year. Company officials …
Read More »
The Independent Uganda: You get the Truth we Pay the Price
